Company
Lunai Bioworks Inc. (LNAI)
Standardized SEC financial data for Lunai Bioworks Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001527728 · NASDAQ · Pharmaceutical Preparations.
Return on equity
833.8%
Free cash flow
-$7.9M
Debt / equity
-0.01×
Current ratio
0.04×
EPS (diluted)
$-1.08
Ratios for fiscal year 2016, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $4.7M | $15.7M | $8.4M | $4.2M | $2.7M | $537K |
| SG&A expense |
Balance sheet
| USD | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $20.7M | $9.2M | $1.9M | $220K | $93K |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$10.5M | -$20.6M | -$15.7M | -$11.8M | -$11.0M | -$7.9M |
| Capital expenditures |
Get LNAI data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/LNAI/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/LNAI/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"